Collection of biological samples for neurological syndromes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on collecting biological samples from patients diagnosed with Paraneoplastic Neurological Syndromes (PNS) or Autoimmune Encephalitis (AE) to improve diagnosis and treatment options. By gathering sera, cerebrospinal fluid, and other biological materials, the study aims to enhance understanding of these rare neuroimmune disorders. The goal is to facilitate faster and more accurate diagnoses, ultimately leading to better patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with consent
* Patient with well-characterized antibodies in serum or cerebrospinal fluid or not
* Patient with neurological disorder compatible with PNS or auto-immune encephalitis

Exclusion Criteria:

* Refusal of consent
* Patient under guardianship

Where it's running

• Neurology
  Besançon, France Recruiting
• Neurology
  Épinal, France Recruiting
• Neurologie
  Grenoble, France Recruiting
• Neurology
  Lille, France Recruiting
• Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes
  Lyon, France Recruiting
• Neurology
  Pointe à Pitre, Guadeloupe, France Not yet recruiting

+12 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Jerome HONNORAT, Pr
• Email: jerome.honnorat@chu-lyon.fr
• Phone: 4 72 35 78 06

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liquid biopsy to detect tumor cells and tumor DNA in people with paraneoplastic neurological syndromes.

  This project tests whether a large blood collection (diagnostic leukapheresis) plus sensitive lab tests can find circulating tumor cells or tumor DNA in adults with paraneoplastic neurological syndromes, whether or not a tumor is already known.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf · NCT07491328

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.